Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marrow Aplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00569842
What this trial is testing

Investigation of the Cylex® ImmuKnow® Assay

Who this might be right for
LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more
Indiana University 45
Testing effectiveness (Phase 2)UnknownNCT02407470
What this trial is testing

Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Navy General Hospital, Beijing 90
Testing effectiveness (Phase 2)Study completedNCT01231841
What this trial is testing

Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT00229619
What this trial is testing

Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

Who this might be right for
Anemia, AplasticRed-Cell Aplasia, PureAnemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 11
Testing effectiveness (Phase 2)Study completedNCT02797964
What this trial is testing

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Who this might be right for
Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
Sierra Oncology LLC - a GSK company 107
Early research (Phase 1)Study completedNCT00001398
What this trial is testing

Stem Cell Factor Medication for Aplastic Anemia

Who this might be right for
Aplastic AnemiaPancytopenia
National Heart, Lung, and Blood Institute (NHLBI) 40
Early research (Phase 1)Study completedNCT00744692
What this trial is testing

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Who this might be right for
Non Malignant DisordersImmunodeficienciesCongenital Marrow Failures+5 more
Duke University 22
Not applicableEnrolling By InvitationNCT07527975
What this trial is testing

Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102

Who this might be right for
Fanconi Anemia
Rocket Pharmaceuticals Inc. 14
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableStudy completedNCT00271089
What this trial is testing

Blood Cell Collection for Future Use in Individuals With Fanconi Anemia

Who this might be right for
Fanconi Anemia
National Heart, Lung, and Blood Institute (NHLBI) 40
Testing effectiveness (Phase 2)Study completedNCT00453388
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia

Who this might be right for
Acute Myeloid Leukemia in Remissionde Novo Myelodysplastic SyndromeFanconi Anemia+1 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01044186
What this trial is testing

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Who this might be right for
Transfusional Iron Overload
Novartis Pharmaceuticals 30
Not applicableActive Not RecruitingNCT03047746
What this trial is testing

Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF

Who this might be right for
Acquired Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaInherited Bone Marrow Failure Syndromes
Children's Hospital of Philadelphia 50
Post-approval studies (Phase 4)Study completedNCT02875743
What this trial is testing

King's Invasive Aspergillosis Study II

Who this might be right for
Aplastic AnemiaLeukemia, Myeloid, AcuteMyelodysplastic Syndromes+1 more
King's College Hospital NHS Trust 120
Not applicableLooking for participantsNCT07629947
What this trial is testing

Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
Peking University People's Hospital 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT07786922
What this trial is testing

Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment

Who this might be right for
Aplastic Anemia
Swedish Orphan Biovitrum 26
Testing effectiveness (Phase 2)Study completedNCT00975975
What this trial is testing

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more
Indiana University 17
Testing effectiveness (Phase 2)Study completedNCT04403321
What this trial is testing

Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

Who this might be right for
Aplastic AnemiaDrug Effect
Peking Union Medical College Hospital 114
Testing effectiveness (Phase 2)Study completedNCT00001964
What this trial is testing

Combination Therapy of Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 104
Post-approval studies (Phase 4)Study completedNCT03896971
What this trial is testing

Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia

Who this might be right for
Aplastic Anemia
Safaa AA Khaled 66
Next Page